0001209191-21-013504.txt : 20210223 0001209191-21-013504.hdr.sgml : 20210223 20210223201209 ACCESSION NUMBER: 0001209191-21-013504 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210219 FILED AS OF DATE: 20210223 DATE AS OF CHANGE: 20210223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kruteck Michael C. CENTRAL INDEX KEY: 0001800864 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 21668007 MAIL ADDRESS: STREET 1: 2701 EASTLAKE AVE E STREET 2: 3RD FLOOR CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 MAUGHAN ROAD CITY: NANAIMO STATE: A1 ZIP: V9X 1J2 BUSINESS PHONE: 2064329325 MAIL ADDRESS: STREET 1: 1100 MAUGHAN ROAD CITY: NANAIMO STATE: A1 ZIP: V9X 1J2 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-19 0 0001731348 Tilray, Inc. TLRY 0001800864 Kruteck Michael C. 2701 EASTLAKE AVE E 3RD FLOOR SEATTLE WA 98102 0 1 0 0 Chief Financial Officer Class 2 Common Stock 2021-02-19 4 A 0 53191 0.00 A 53191 D Class 2 Common Stock 2021-02-19 4 F 0 23476 0.00 D 29715 D Restricted Stock Units 2021-02-19 4 A 0 53192 0.00 A Class 2 Common Stock 53192 53192 D On August 5, 2020, the Reporting Person was granted restricted stock units ("RSU"), which represented a contingent right to receive 106,383 shares of the Issuer's Class 2 Common Stock. The RSU was to vest 50% upon the filing date of the Issuer's Annual Report on Form 10-K for the year ended December 31, 2020, provided that the Issuer achieved certain performance criteria for fourth quarter 2020 (the "Performance Criteria"). The Performance Criteria was met on February 19, 2021, resulting in the vesting of 53,191 shares under this RSU. Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of the RSU. Each RSU represents a contingent right to receive one share of the Issuer's Class 2 Common Stock. On February 19, 2021 the Performance Criteria was met allowing for the remaining 50% of the RSU (53,192 shares) to vest on January 1, 2022, subject to the Reporting Person providing continuous service to the Issuer until such date. /s/ Julia Stark, Attorney-in-fact 2021-02-23